---
$id: https://graph.org.ai/products/commodity/51263117
$type: Product
source: UNSPSC
code: "51263117"
title: "Carazolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carazolol

**UNSPSC Code**: 51263117
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29PW75S82A, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((1-methylethyl)amino)- but generally known as carazolol, which bears US NIH Compound Identifier 71739. Carazolol most often comes in base, glucuronide, and hydrochloride forms. European Medicines Agency schedules Carazolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06086MIG. The term CARAZOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). CARAZOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carazolol under HS 29339990 and SITC 51577. As of Q4 2014, CARAZOLOL remains the US FDA Preferred Term for this commodity. Carazolol bears US NLM identifiers UMLS ID C0054636 and NCI Concept Code C77941. SMILES: O(C1C2C3C([NH]C2CCC1)CCCC3)CC(O)CNC(C)C.

